Andere talen Zeo ScientifiX, Inc.

Aandelen

ZEOX

US68621D2062

Beurs gesloten - OTC Markets Andere beurzen 18:34:14 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,01 ^USD	-15,83%		-22,31%	-0,98%

18/03	Zeo ScientifiX, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 januari 2024	CI
05/03	Zeo ScientifiX, Inc. heeft haar ticker veranderd van OCEL naar ZEOX	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	18/03
Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL	05/03
Organicell Regenerative Medicine, Inc. will Change its Name to Zeo ScientifiX, Inc	20/02
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	29/01
Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K	27/11
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	14-09-23
Organicell Regenerative Medicine, Inc. announced a financing transaction	15-08-23
Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K	09-08-23
An unknown buyer acquired Laboratory Facility Located in Basalt, Colorado from Organicell Regenerative Medicine, Inc. for $1.25 million.	09-08-23
Organicell Regenerative Medicine, Inc. Reports Interim Results of Phase 1/2A Research Program	26-07-23
Organicell Regenerative Medicine, Inc. Announces Resignation of Maria Ines Mitrani as Director	11-07-23
Organicell Welcomes Howard Golub as Its New EVP/CSO	29-06-23
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	16-06-23
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	06-06-23
Organicell Regenerative Medicine, Inc. Announces Executive Changes	06-06-23
Organicell Regenerative Medicine, Inc. Announces Management Changes	06-06-23
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	15-05-23
Organicell Regenerative Medicine, Inc. Terminates Albert Mitrani as Its Executive Vice President of Sales	15-05-23
ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	01-05-23
Organicell Regenerative Medicine, Inc. Announces Termination of Dr. Maria Ines Mitrani as its Chief Scientific Officer	01-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zeo ScientifiX, Inc.

Aandelen

ZEOX

US68621D2062

Andere talen

Filters